Protagonist Therapeutics Inc
PTGX
Market Cap$3.67B
Close$
$1.33
97.8% downside
Current Fair Value
97.8% downsideOvervalued by 97.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.67 Billion |
|---|---|
| Enterprise Value | $3.53 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $4.47 |
| Beta | 2.33 |
| Outstanding Shares | 63,511,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 72.07 |
|---|---|
| PEG | 531.04 |
| Price to Sales | 19.87 |
| Price to Book Ratio | 5.96 |
| Enterprise Value to Revenue | 17.36 |
| Enterprise Value to EBIT | 147.83 |
| Enterprise Value to Net Income | 67 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data